Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jun;13(2):201.
doi: 10.1007/s13181-017-0613-9. Epub 2017 Apr 5.

In Reply: "The importance of recognizing cannabinoid hyperemesis syndrome from synthetic marijuana use"

Affiliations
Editorial

In Reply: "The importance of recognizing cannabinoid hyperemesis syndrome from synthetic marijuana use"

Cecilia J Sorensen et al. J Med Toxicol. 2017 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Sources of Funding

Dr. Borgelt receives support from the Colorado Department of Public Health and Environment and the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Phillips receives support from NIH on Drug Abuse R15 DA041656 and R01 DA034957, and Dr. Monte receives support from NIH 1 K23 GM110516 and NIH CTSI UL1 TR001082.

Comment on

References

    1. Bick BL, Szostek JH, Mangan TF. Synthetic cannabinoid leading to cannabinoid hyperemesis syndrome. Mayo Clin Proc. 2014;89(8):1168–1169. doi: 10.1016/j.mayocp.2014.06.013. - DOI - PubMed
    1. Ukaigwe A, Karmacharya P, Donato A. A gut gone to pot: a case of cannabinoid hyperemesis syndrome due to K2, a synthetic cannabinoid. Case Rep Emerg Med. 2014;2014:167098. - PMC - PubMed
    1. Hopkins CY, Gilchrist BL. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids. J Emerg Med. 2013;45(4):544–546. doi: 10.1016/j.jemermed.2012.11.034. - DOI - PubMed
    1. Fattore L, Fratta W. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci. 2011;5:60. doi: 10.3389/fnbeh.2011.00060. - DOI - PMC - PubMed
    1. Sorensen CJ, et al. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment-a systematic review. J Med Toxicol. 2017;13(1):71–87. doi: 10.1007/s13181-016-0595-z. - DOI - PMC - PubMed

LinkOut - more resources